Home › Neuroblastoma › New York › The Bronx
Neuroblastoma clinical trials in The Bronx, NY
4 studies for Neuroblastoma are looking for participants at sites in and around The Bronx (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
RecruitingPhase 3
- Montefiore Medical Center - Moses Campus, The Bronx
Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)
RecruitingPhase 3
- Montefiore Medical Center - Moses Campus, The Bronx
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
RecruitingPhase 2
- Albert Einstein College of Medicine, Children's Hospital at Montefiore, The Bronx
A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors
RecruitingPhase 2
- Children's Hospital at Montefiore, The Bronx
About Neuroblastoma
Neuroblastoma is a cancer in nerve tissue in the adrenal gland, neck, chest, or spinal cord. It often affects young children. Read about treatments.
More about Neuroblastoma on MedlinePlus
Neuroblastoma trials in other cities
- Boston, MA13 studies
- Washington, DC11 studies
- New York City, NY10 studies
- Memphis, TN9 studies
- Philadelphia, PA9 studies
- Dallas, TX9 studies
- St. Louis, MO9 studies
- Aurora, CO8 studies
- Hartford, CT8 studies
- Minneapolis, MN8 studies
- Birmingham, AL8 studies
- Atlanta, GA7 studies
Other studies in The Bronx
- Non-Small Cell Lung Cancer25 studies
- Breast Cancer17 studies
- Acute Myeloid Leukemia15 studies
- Lung Cancer13 studies
- Cancer (all types)12 studies
- Cardiovascular Disease12 studies
- Prostate Cancer11 studies
- Heart Failure11 studies
- Head and Neck Squamous Cell Carcinoma9 studies
- Colorectal Cancer9 studies
- Metastatic Cancer9 studies
- Asthma9 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.